Macrogenics Inc Stock Ownership - Who owns Macrogenics?

Insider buying vs selling

Have Macrogenics Inc insiders been buying or selling?
Jeffrey Stuart PetersSenior VP and General Counsel2024-04-043,165$18.22
Jeffrey Stuart PetersSenior VP and General Counsel2024-04-0442,500$4.82
Jeffrey Stuart PetersSenior VP and General Counsel2024-04-0442,500$15.07
Jeffrey Stuart PetersSenior VP and General Counsel2024-04-04147$15.51
Jeffrey Stuart PetersSenior VP and General Counsel2024-04-04232$16.38
Jeffrey Stuart PetersSenior VP and General Counsel2024-04-045,351$17.74
Jeffrey Stuart PetersSenior VP and General Counsel2024-03-0610,875$11.50
Jeffrey Stuart PetersSenior VP and General Counsel2024-03-068,750$10.15
Jeffrey Stuart PetersSenior VP and General Counsel2024-03-0619,625$21.50
Eric Blasius RisserChief Operating Officer2024-03-0426,159$19.63

1 of 4

MGNX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MGNX insiders and whales buy or sell their stock.

MGNX Shareholders

What type of owners hold Macrogenics Inc stock?
Bellevue Group Ag15.94%9,953,313$160.25MInstitution
Target N. V. Biotech15.91%9,929,963$159.87MInsider
Blackrock Inc9.84%6,140,349$98.86MInstitution
T Rowe Price Investment Management Inc9.03%5,639,994$90.80MInstitution
Armistice Capital LLC7.32%4,572,000$73.61MInstitution
Vanguard Group Inc6.90%4,309,394$69.38MInstitution
Ra Capital Management LP6.49%4,053,077$65.25MInstitution
Frazier Life Sciences Management LP3.85%2,401,704$38.67MInstitution
Tpg Group Holdings Sbs Advisors Inc3.54%2,208,762$35.56MInsider
State Street Corp3.48%2,174,022$35.00MInstitution

1 of 3

MGNX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MGNX72.54%27.46%Net BuyingNet Selling
IMNM36.00%9.90%Net Buying
BCYC54.61%45.39%Net SellingNet Selling

Macrogenics Stock Ownership FAQ

Who owns Macrogenics?

Macrogenics (NASDAQ: MGNX) is owned by 99.06% institutional shareholders, 37.51% Macrogenics insiders, and 0.00% retail investors. Target N. V. Biotech is the largest individual Macrogenics shareholder, owning 9.93M shares representing 15.91% of the company. Target N. V. Biotech's Macrogenics shares are currently valued at $159.57M.

If you're new to stock investing, here's how to buy Macrogenics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.